HEIDI VORAC: Open Payments
NPI 1669874608 · ROCK ISLAND, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$711 in 39 payments from 12 companies in 2025. Trend: 2023 $249 · 2024 $685 · 2025 $711
Food & beverage: $711
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 7 | $110 |
| AstraZeneca Pharmaceuticals LP | 5 | $106 |
| ABBVIE INC. | 4 | $101 |
| PFIZER INC. | 6 | $96 |
| Novo Nordisk Inc | 5 | $81 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $66 |
| Otsuka America Pharmaceutical, Inc. | 2 | $47 |
| Exact Sciences Corporation | 2 | $30 |
| Almatica Pharma LLC | 1 | $22 |
| Eisai Inc. | 1 | $21 |
Products named: VRAYLAR, MOUNJARO, CAPLYTA, ELIQUIS, AIRSUPRA, REXULTI, NURTEC ODT, Wegovy.
Industry payments across IL — which companies pay providers there.
